Global EPharmacy Market Size study, by Drug Type (Prescription Drugs, OTT Drugs), by Product Type (Skin Care, Dental, Cold Flu, Vitamins, Weight Loss, Others) and Regional Forecasts 2018-2025


Report ID : RC-43797 Category : Service Industry Published Date : Jun-19
Publisher : Bizwit Research Pages : 200 Format : PDF
Global EPharmacy Market valued approximately USD 38.05 billion in 2017  is anticipated to grow with a healthy growth rate of more than 15.20% over the forecast period 2018-2025. The EPharmacy Market is continuously growing in the global scenario at significant pace. The pharmacy, also popularly known as online pharmacy, or mail-order pharmacy, or Internet pharmacy, is a pharmacy operating via Internet and does the sending of orders to its customers via shipping companies or mail. E-Pharmacies include pharmacy benefit manager. Pharmacy benefit manager is a huge group prescription drug plans administrator. Surge in the number of internet users in both developed and developing countries, enhance access to web-based & online services and surging implementation of E-Prescriptions in Hospitals and diagnostic centers are the substantial driving factors of the market during the forecast period. Moreover, increasing adoption of e-commerce platforms in epharmacy is the major factors that likely to create numerous opportunity in the near future. However, surging number of illegal online pharmacies and low adoption of advanced technology in underdeveloped region are the factors that limiting the growth of the market during the forecast period. 
The regional analysis of Global EPharmacy Market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading/significant region across the world in terms of market share due to increasing adoption of ecommerce, increasing frequency of online orders and rising aging population in the region. Europe is estimated to grow at stable growth rate in the global EPharmacy market over the upcoming years. Further, Asia-pacific anticipated to exhibit higher growth rate / CAGR over the forecast period 2018-2025 owing to presence of large patient base and rising health awareness among people in the region.
The major market player included in this report are:
CVS Health Corporation
DocMorris
Giant Eagle Inc.
Rowlands Pharmacy
The Kroger Corporation
Walmart Stores Inc.                    

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below: 

By Drug Type:

Prescription Drugs
OTT Drugs

By Product Type:

Skin Care
Dental
Cold Flu
Vitamins
Weight Loss
Others

By Regions:
North America
U.S.
Canada
Europe
UK
Germany
Asia Pacific
China
India
Japan
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year ? 2015, 2016
Base year ? 2017
Forecast period ? 2018 to 2025

Target Audience of the Global EPharmacy Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors
 TABLE OF CONTENTS

Chapter 1.	Executive Summary 
1.1.	Market Snapshot
1.2.	Key Trends
1.3.	Global & Segmental Market Estimates & Forecasts, 2015-2025 (USD Billion)
1.3.1.	EPharmacy Market, by Drug Type, 2015-2025 (USD Billion)
1.3.2.	EPharmacy Market, by Product Type, 2015-2025 (USD Billion)
1.3.3.	EPharmacy Market, by Region, 2015-2025 (USD Billion)
1.4.	Estimation Methodology
1.5.	Research Assumption
Chapter 2.	EPharmacy Market Definition and Scope 
2.1.	Objective of the Study	
2.2.	Market Definition & Scope
2.2.1.	Industry Evolution
2.2.2.	Scope of the Study
2.3.	Years Considered for the Study
2.4.	Currency Conversion Rates
Chapter 3.	EPharmacy Market Dynamics	
3.1.	See Saw Analysis
3.1.1.	Market Drivers
3.1.2.	Market Challenges
3.1.3.	Market Opportunities
Chapter 4.	EPharmacy Market Industry Analysis
4.1.	Porter?s 5 Force Model
4.1.1.	Bargaining Power of Buyers
4.1.2.	Bargaining Power of Suppliers
4.1.3.	Threat of New Entrants
4.1.4.	Threat of Substitutes
4.1.5.	Competitive Rivalry
4.1.6.	Futuristic Approach to Porter?s 5 Force Model
4.2.	PEST Analysis
4.2.1.	Political Scenario
4.2.2.	Economic Scenario
4.2.3.	Social Scenario
4.2.4.	Technological Scenario
4.3.	Value Chain Analysis
4.3.1.	Supplier
4.3.2.	Manufacturers/Service Provider
4.3.3.	Distributors
4.3.4.	End-Users
4.4.	Key Buying Criteria
4.5.	Regulatory Framework
4.6.	Cost Structure Analysis
4.6.1.	Raw Material Cost Analysis
4.6.2.	Manufacturing Cost Analysis
4.6.3.	Labour Cost Analysis 
4.7.	Investment Vs Adoption Scenario
4.8.	Analyst Recommendation & Conclusion
Chapter 5.	EPharmacy Market, by Drug Type
5.1.	Market Snapshot 
5.2.	Market Performance - Potential Model
5.3.	Key Market Players
5.4.	EPharmacy Market, Sub Segment Analysis
5.4.1.	Prescription Drugs
5.4.1.1.	Market estimates & forecasts, 2015-2025 (USD Billion)
5.4.1.2.	Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
5.4.2.	OTT Drugs
5.4.2.1.	Market estimates & forecasts, 2015-2025 (USD Billion)
5.4.2.2.	Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
Chapter 6.	EPharmacy Market, by Product Types 
6.1.	Market Snapshot 
6.2.	Market Performance - Potential Model
6.3.	Key Market Players
6.4.	EPharmacy Market, Sub Segment Analysis
6.4.1.	Skin Care
6.4.1.1.	Market estimates & forecasts, 2015-2025 (USD Billion)
6.4.1.2.	Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
6.4.2.	Dental
6.4.2.1.	Market estimates & forecasts, 2015-2025 (USD Billion)
6.4.2.2.	Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
6.4.3.	Cold Flu
6.4.3.1.	Market estimates & forecasts, 2015-2025 (USD Billion)
6.4.3.2.	Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
6.4.4.	Vitamins
6.4.4.1.	Market estimates & forecasts, 2015-2025 (USD Billion)
6.4.4.2.	Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
6.4.5.	Weight Loss
6.4.5.1.	Market estimates & forecasts, 2015-2025 (USD Billion)
6.4.5.2.	Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
6.4.6.	Others
6.4.6.1.	Market estimates & forecasts, 2015-2025 (USD Billion)
6.4.6.2.	Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
Chapter 7.	EPharmacy Market, by Regional Analysis
7.1.	EPharmacy Market, Regional Market Snapshot (2015-2025)
7.2.	North America EPharmacy Market Snapshot
7.2.1.	U.S.
7.2.1.1.	Market estimates & forecasts, 2015-2025 (USD Billion)
7.2.1.2.	Drug Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.2.1.3.	Product Types breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.2.2.	Canada
7.2.2.1.	Market estimates & forecasts, 2015-2025 (USD Billion)
7.2.2.2.	Drug Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.2.2.3.	Product Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.3.	Europe EPharmacy Market  Snapshot
7.3.1.	U.K. 
7.3.1.1.	Market estimates & forecasts, 2015-2025 (USD Billion)
7.3.1.2.	Drug Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.3.1.3.	Product Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.3.2.	Germany 
7.3.2.1.	Market estimates & forecasts, 2015-2025 (USD Billion)
7.3.2.2.	Drug Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.3.2.3.	Product Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.3.3.	France 
7.3.3.1.	Market estimates & forecasts, 2015-2025 (USD Billion)
7.3.3.2.	Drug Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.3.3.3.	Product Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.3.4.	Rest of Europe
7.3.4.1.	Market estimates & forecasts, 2015-2025 (USD Billion)
7.3.4.2.	Drug Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.3.4.3.	Product Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.4.	Asia EPharmacy Market Snapshot
7.4.1.	China 
7.4.1.1.	Market estimates & forecasts, 2015-2025 (USD Billion)
7.4.1.2.	Drug Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.4.1.3.	Product Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.4.2.	India 
7.4.2.1.	Market estimates & forecasts, 2015-2025 (USD Billion)
7.4.2.2.	Drug Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.4.2.3.	Product Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.4.3.	Japan
7.4.3.1.	Market estimates & forecasts, 2015-2025 (USD Billion)
7.4.3.2.	Drug Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.4.3.3.	Product Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.4.4.	Rest of Asia Pacific
7.4.4.1.	Market estimates & forecasts, 2015-2025 (USD Billion)
7.4.4.2.	Drug Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.4.4.3.	Product Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.5.	Latin America EPharmacy Market Snapshot
7.5.1.	Brazil 
7.5.1.1.	Market estimates & forecasts, 2015-2025 (USD Billion)
7.5.1.2.	Drug Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.5.1.3.	Product Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.5.2.	Mexico 
7.5.2.1.	Market estimates & forecasts, 2015-2025 (USD Billion)
7.5.2.2.	Drug Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.5.2.3.	Product Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.6.	Rest of The World 
7.6.1.	South America
7.6.1.1.	Market estimates & forecasts, 2015-2025 (USD Billion)
7.6.1.2.	Drug Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.6.1.3.	Product Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.6.2.	Middle East and Africa
7.6.2.1.	Market estimates & forecasts, 2015-2025 (USD Billion)
7.6.2.2.	Drug Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.6.2.3.	Product Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
Chapter 8.	Competitive Intelligence
8.1.	Company Market Share (Subject to Data Availability)
8.2.	Top Market Strategies
8.3.	Company Profiles
8.3.1.	CVS Health Corporation
8.3.1.1.	Overview
8.3.1.2.	Financial (Subject to Data Availability)
8.3.1.3.	Summary
8.3.1.4.	Recent Developments
8.3.2.	DocMorris
8.3.3.	Giant Eagle Inc.
8.3.4.	Rowlands Pharmacy
8.3.5.	The Kroger Corporation
8.3.6.	Walmart Stores Inc.  
Chapter 9.	Research Process
9.1.	Research Process
9.1.1.	Data Mining
9.1.2.	Analysis
9.1.3.	Market Estimation
9.1.4.	Validation
9.1.5.	Publishing
9.1.6.	Research Assumption

Sidebar Menu